These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
237 related items for PubMed ID: 19282292
1. Breast carcinoma with chondroid differentiation: a clinicopathologic study of 21 triple negative (ER-, PR-, Her2/neu-) cases. Gwin K, Wheeler DT, Bossuyt V, Tavassoli FA. Int J Surg Pathol; 2010 Feb; 18(1):27-35. PubMed ID: 19282292 [Abstract] [Full Text] [Related]
2. Correlation between genetic and biological aspects in primary non-metastatic breast cancers and corresponding synchronous axillary lymph node metastasis. D'Andrea MR, Limiti MR, Bari M, Zambenedetti P, Montagutti A, Ricci F, Pappagallo GL, Sartori D, Vinante O, Mingazzini PL. Breast Cancer Res Treat; 2007 Mar; 101(3):279-84. PubMed ID: 16835704 [Abstract] [Full Text] [Related]
3. Apocrine carcinoma as triple-negative breast cancer: novel definition of apocrine-type carcinoma as estrogen/progesterone receptor-negative and androgen receptor-positive invasive ductal carcinoma. Tsutsumi Y. Jpn J Clin Oncol; 2012 May; 42(5):375-86. PubMed ID: 22450930 [Abstract] [Full Text] [Related]
5. Bone metastasis is strongly associated with estrogen receptor-positive/progesterone receptor-negative breast carcinomas. Wei B, Wang J, Bourne P, Yang Q, Hicks D, Bu H, Tang P. Hum Pathol; 2008 Dec; 39(12):1809-15. PubMed ID: 18715613 [Abstract] [Full Text] [Related]
6. [Clinicopathologic analysis of the nipple-areolar complex occult involvement in early stage breast carcinoma]. Wang SY, Peng DF, Cai ZG, Zhang RZ, Yao TJ, Zhang H, Yang M, Dong HM. Zhonghua Zhong Liu Za Zhi; 2008 Mar; 30(3):203-6. PubMed ID: 18756937 [Abstract] [Full Text] [Related]
7. Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. Steinman S, Wang J, Bourne P, Yang Q, Tang P. Ann Clin Lab Sci; 2007 Mar; 37(2):127-34. PubMed ID: 17522367 [Abstract] [Full Text] [Related]
8. Primary breast cancer phenotypes associated with propensity for central nervous system metastases. Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R. Cancer; 2006 Aug 15; 107(4):696-704. PubMed ID: 16826579 [Abstract] [Full Text] [Related]
10. Clinicopathological analyses of triple negative breast cancer using surveillance data from the Registration Committee of the Japanese Breast Cancer Society. Iwase H, Kurebayashi J, Tsuda H, Ohta T, Kurosumi M, Miyamoto K, Yamamoto Y, Iwase T. Breast Cancer; 2010 Apr 15; 17(2):118-24. PubMed ID: 19466512 [Abstract] [Full Text] [Related]
16. Microinvasive breast cancer: ER, PR, and HER-2/neu status and clinical outcomes after breast-conserving therapy or mastectomy. Margalit DN, Sreedhara M, Chen YH, Catalano PJ, Nguyen PL, Golshan M, Overmoyer BA, Harris JR, Brock JE. Ann Surg Oncol; 2013 Mar 15; 20(3):811-8. PubMed ID: 22956068 [Abstract] [Full Text] [Related]
17. FOXA1 expression in breast cancer--correlation with luminal subtype A and survival. Badve S, Turbin D, Thorat MA, Morimiya A, Nielsen TO, Perou CM, Dunn S, Huntsman DG, Nakshatri H. Clin Cancer Res; 2007 Aug 01; 13(15 Pt 1):4415-21. PubMed ID: 17671124 [Abstract] [Full Text] [Related]
18. PIK3CA mutations mostly begin to develop in ductal carcinoma of the breast. Li H, Zhu R, Wang L, Zhu T, Li Q, Chen Q, Wang H, Zhu H. Exp Mol Pathol; 2010 Feb 01; 88(1):150-5. PubMed ID: 19818761 [Abstract] [Full Text] [Related]